Anemonin Attenuates RANKL-Induced Osteoclastogenesis and Ameliorates LPS-Induced Inflammatory Bone Loss in Mice via Modulation of NFATc1

• Hauptverfasser: Huanhuan Hou (Verfasst von), Qisheng Peng (Verfasst von), Shaoming Wang (Verfasst von), Yuxin Zhang (Verfasst von), Jinjin Cao (Verfasst von), Yuming Deng (Verfasst von), Yingjian Wang (Verfasst von), Wan-chun Sun (Verfasst von), Hong-bing Wang (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2020-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Osteoporosis is a metabolic bone disease characterized by insufficient osteoblastic function and/or excessive osteoclastic activity. One promising strategy for treating osteoporosis is inhibiting excessive osteoclast resorbing activity. Previous studies have revealed that anemonin (ANE), isolated fr...